References analysis of the Wikipedia article "CD44" in the Galician version

doi.org

dx.doi.org

Goodison S, Urquidi V, Tarin D (agosto de 1999). "CD44 cell adhesion molecules". Molecular Pathology 52 (4): 189–96. PMC 395698. PMID 10694938. doi:10.1136/mp.52.4.189.

Oxley SM, Sackstein R (novembro de 1994). "Detection of an L-selectin ligand on a hematopoietic progenitor cell line". Blood 84 (10): 3299–306. PMID 7524735. doi:10.1182/blood.V84.10.3299.3299.

Alves CS, Burdick MM, Thomas SN, Pawar P, Konstantopoulos K (abril de 2008). "The dual role of CD44 as a functional P-selectin ligand and fibrin receptor in colon carcinoma cell adhesion". American Journal of Physiology. Cell Physiology 294 (4): C907–16. PMID 18234849. doi:10.1152/ajpcell.00463.2007.

Hanley WD, Burdick MM, Konstantopoulos K, Sackstein R (xullo de 2005). "CD44 on LS174T colon carcinoma cells possesses E-selectin ligand activity". Cancer Research 65 (13): 5812–7. PMID 15994957. doi:10.1158/0008-5472.CAN-04-4557.

Sackstein R, Dimitroff CJ (outubro de 2000). "A hematopoietic cell L-selectin ligand that is distinct from PSGL-1 and displays N-glycan-dependent binding activity". Blood 96 (8): 2765–74. PMID 11023510. doi:10.1182/blood.V96.8.2765.

Sackstein R, Merzaban JS, Cain DW, Dagia NM, Spencer JA, Lin CP, Wohlgemuth R (febreiro de 2008). "Ex vivo glycan engineering of CD44 programs human multipotent mesenchymal stromal cell trafficking to bone". Nature Medicine 14 (2): 181–7. PMID 18193058. doi:10.1038/nm1703.

Dimitroff CJ, Lee JY, Rafii S, Fuhlbrigge RC, Sackstein R (xuño de 2001). "CD44 is a major E-selectin ligand on human hematopoietic progenitor cells". The Journal of Cell Biology 153 (6): 1277–86. PMC 2192031. PMID 11402070. doi:10.1083/jcb.153.6.1277.

Burdick MM, Chu JT, Godar S, Sackstein R (maio de 2006). "HCELL is the major E- and L-selectin ligand expressed on LS174T colon carcinoma cells". The Journal of Biological Chemistry 281 (20): 13899–905. PMID 16565092. doi:10.1074/jbc.M513617200.

Hanley WD, Napier SL, Burdick MM, Schnaar RL, Sackstein R, Konstantopoulos K (febreiro de 2006). "Variant isoforms of CD44 are P- and L-selectin ligands on colon carcinoma cells". FASEB Journal 20 (2): 337–9. PMID 16352650. doi:10.1096/fj.05-4574fje.

Napier SL, Healy ZR, Schnaar RL, Konstantopoulos K (febreiro de 2007). "Selectin ligand expression regulates the initial vascular interactions of colon carcinoma cells: the roles of CD44v and alternative sialofucosylated selectin ligands". The Journal of Biological Chemistry 282 (6): 3433–41. PMID 17135256. doi:10.1074/jbc.M607219200.

Thomas SN, Zhu F, Schnaar RL, Alves CS, Konstantopoulos K (xuño de 2008). "Carcinoembryonic antigen and CD44 variant isoforms cooperate to mediate colon carcinoma cell adhesion to E- and L-selectin in shear flow". The Journal of Biological Chemistry 283 (23): 15647–55. PMC 2414264. PMID 18375392. doi:10.1074/jbc.M800543200.

Sackstein R (xullo de 2009). "Glycosyltransferase-programmed stereosubstitution (GPS) to create HCELL: engineering a roadmap for cell migration". Immunological Reviews 230 (1): 51–74. PMC 4306344. PMID 19594629. doi:10.1111/j.1600-065X.2009.00792.x.

Alves CS, Yakovlev S, Medved L, Konstantopoulos K (xaneiro de 2009). "Biomolecular characterization of CD44-fibrin(ogen) binding: distinct molecular requirements mediate binding of standard and variant isoforms of CD44 to immobilized fibrin(ogen)". The Journal of Biological Chemistry 284 (2): 1177–89. PMC 2613610. PMID 19004834. doi:10.1074/jbc.M805144200.

Li F, Tiede B, Massagué J, Kang Y (xaneiro de 2007). "Beyond tumorigenesis: cancer stem cells in metastasis". Cell Research 17 (1): 3–14. PMID 17179981. doi:10.1038/sj.cr.7310118.

Griffith JS, Liu YG, Tekmal RR, Binkley PA, Holden AE, Schenken RS (abril de 2010). "Menstrual endometrial cells from women with endometriosis demonstrate increased adherence to peritoneal cells and increased expression of CD44 splice variants". Fertility and Sterility 93 (6): 1745–9. PMC 2864724. PMID 19200980. doi:10.1016/j.fertnstert.2008.12.012.

Wang SJ, Wong G, de Heer AM, Xia W, Bourguignon LY (agosto de 2009). "CD44 variant isoforms in head and neck squamous cell carcinoma progression". The Laryngoscope 119 (8): 1518–30. PMC 2718060. PMID 19507218. doi:10.1002/lary.20506.

Quere R, Andradottir S, Brun A, Zubarev R, Karlsson G, Olsson K, Magnusson M, Cammenga J, Karlsson S (marzo de 2010). "High levels of the adhesion molecule CD44 on leukemic cells generate acute myeloid leukemia relapse after withdrawal of the initial transforming event". Leukemia 25 (3): 515–526. PMC 3072510. PMID 21116281. doi:10.1038/leu.2010.281.

Eibl RH, Pietsch T, Moll J, Skroch-Angel P, Heider KH, von Ammon K, Wiestler OD, Ponta H, Kleihues P, Herrlich P (decembro de 1995). "Expression of variant CD44 epitopes in human astrocytic brain tumors". Journal of Neuro-Oncology 26 (3): 165–70. PMID 8750182. doi:10.1007/bf01052619.

Naor D, Nedvetzki S, Golan I, Melnik L, Faitelson Y (novembro de 2002). "CD44 in cancer". Critical Reviews in Clinical Laboratory Sciences 39 (6): 527–79. PMID 12484499. doi:10.1080/10408360290795574.

Luxton, Hayley J.; Simpson, Benjamin S.; Mills, Ian G.; Brindle, Nicola R.; Ahmed, Zeba; Stavrinides, Vasilis; Heavey, Susan; Stamm, Stefan; Whitaker, Hayley C. (2019-08-23). "The Oncogene Metadherin Interacts with the Known Splicing Proteins YTHDC1, Sam68 and T-STAR and Plays a Novel Role in Alternative mRNA Splicing". Cancers 11 (9): 1233. ISSN 2072-6694. PMC 6770463. PMID 31450747. doi:10.3390/cancers11091233.

Bourguignon LY, Singleton PA, Zhu H, Diedrich F (agosto de 2003). "Hyaluronan-mediated CD44 interaction with RhoGEF and Rho kinase promotes Grb2-associated binder-1 phosphorylation and phosphatidylinositol 3-kinase signaling leading to cytokine (macrophage-colony stimulating factor) production and breast tumor progression". The Journal of Biological Chemistry 278 (32): 29420–34. PMID 12748184. doi:10.1074/jbc.M301885200.

Chen X, Khajeh JA, Ju JH, Gupta YK, Stanley CB, Do C, Heller WT, Aggarwal AK, Callaway DJ, Bu Z (marzo de 2015). "Phosphatidylinositol 4,5-bisphosphate clusters the cell adhesion molecule CD44 and assembles a specific CD44-Ezrin heterocomplex, as revealed by small angle neutron scattering". The Journal of Biological Chemistry 290 (10): 6639–52. PMC 4358296. PMID 25572402. doi:10.1074/jbc.M114.589523.

Midgley AC, Rogers M, Hallett MB, Clayton A, Bowen T, Phillips AO, Steadman R (maio de 2013). "TGF-β1-stimulated fibroblast to myofibroblast differentiation is mediated by HA-facilitated EGFR and CD44 co-localization in lipid rafts". The Journal of Biological Chemistry 288 (21): 14824–38. PMC 3663506. PMID 23589287. doi:10.1074/jbc.M113.451336.

Jalkanen S, Jalkanen M (Feb 1992). "Lymphocyte CD44 binds the COOH-terminal heparin-binding domain of fibronectin". The Journal of Cell Biology 116 (3): 817–25. PMC 2289325. PMID 1730778. doi:10.1083/jcb.116.3.817.

Ilangumaran S, Briol A, Hoessli DC (maio de 1998). "CD44 selectively associates with active Src family protein tyrosine kinases Lck and Fyn in glycosphingolipid-rich plasma membrane domains of human peripheral blood lymphocytes". Blood 91 (10): 3901–8. PMID 9573028. doi:10.1182/blood.V91.10.3901.

Aruffo A, Stamenkovic I, Melnick M, Underhill C, Seed B (Jul 1990). "CD44 is the principal cell surface receptor for hyaluronate". Cell 61 (7): 1303–13. PMID 1694723. doi:10.1016/0092-8674(90)90694-A.

Taher TE, Smit L, Griffioen AW, Schilder-Tol EJ, Borst J, Pals ST (febreiro de 1996). "Signaling through CD44 is mediated by tyrosine kinases. Association with p56lck in T lymphocytes". The Journal of Biological Chemistry 271 (5): 2863–7. PMID 8576267. doi:10.1074/jbc.271.5.2863.

Zohar R, Suzuki N, Suzuki K, Arora P, Glogauer M, McCulloch CA, Sodek J (xullo de 2000). "Intracellular osteopontin is an integral component of the CD44-ERM complex involved in cell migration". Journal of Cellular Physiology 184 (1): 118–30. PMID 10825241. doi:10.1002/(SICI)1097-4652(200007)184:1<118::AID-JCP13>3.0.CO;2-Y.

Bourguignon LY, Zhu H, Shao L, Chen YW (marzo de 2001). "CD44 interaction with c-Src kinase promotes cortactin-mediated cytoskeleton function and hyaluronic acid-dependent ovarian tumor cell migration". The Journal of Biological Chemistry 276 (10): 7327–36. PMID 11084024. doi:10.1074/jbc.M006498200.

Shi XR, Leng L, Wang T, Wang WK, Du X, Li J, McDonald C, Chen Z, Murphy JW, Lolis E, Noble P, Knudson W, Bucala R (outubro de 2006). "CD44Is the Signaling Component of the Macrophage Migration Inhibitory Factor-CD74 Receptor Complex". Journal of Immunity 25 (4): 595–606. PMC 3707630. PMID 17045821. doi:10.1016/j.immuni.2006.08.020.

nih.gov

ncbi.nlm.nih.gov

Spring FA, Dalchau R, Daniels GL, Mallinson G, Judson PA, Parsons SF, Fabre JW, Anstee DJ (maio de 1988). "The Ina and Inb blood group antigens are located on a glycoprotein of 80,000 MW (the CDw44 glycoprotein) whose expression is influenced by the In(Lu) gene". Immunology 64 (1): 37–43. PMC 1385183. PMID 2454887.

Goodison S, Urquidi V, Tarin D (agosto de 1999). "CD44 cell adhesion molecules". Molecular Pathology 52 (4): 189–96. PMC 395698. PMID 10694938. doi:10.1136/mp.52.4.189.

Oxley SM, Sackstein R (novembro de 1994). "Detection of an L-selectin ligand on a hematopoietic progenitor cell line". Blood 84 (10): 3299–306. PMID 7524735. doi:10.1182/blood.V84.10.3299.3299.

Li F, Tiede B, Massagué J, Kang Y (xaneiro de 2007). "Beyond tumorigenesis: cancer stem cells in metastasis". Cell Research 17 (1): 3–14. PMID 17179981. doi:10.1038/sj.cr.7310118.

Sillanpää S, Anttila MA, Voutilainen K, Tammi RH, Tammi MI, Saarikoski SV, Kosma VM (novembro de 2003). "CD44 expression indicates favorable prognosis in epithelial ovarian cancer". Clinical Cancer Research 9 (14): 5318–24. PMID 14614016.

Assimakopoulos D, Kolettas E, Patrikakos G, Evangelou A (outubro de 2002). "The role of CD44 in the development and prognosis of head and neck squamous cell carcinomas". Histology and Histopathology 17 (4): 1269–81. PMID 12371152.

CD44 (Galician Wikipedia)

aacrjournals.org

clincancerres.aacrjournals.org

archive.org

doi.org

dx.doi.org

nih.gov

ncbi.nlm.nih.gov

worldcat.org